Your account is not claimed yet. You can sign up with ORCID to claim your account.

Daniel P Regan (Daniel Regan)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Venues

Veterinary and comparative oncology

Veterinary pathology

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular cancer therapeutics

Colorado State University

Colorado State University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Colorado State University Aug 1o 2017

United States

Assistant professor :: Microbiology, Immunology, and Pathology

Education History

Colorado State University Jul 1o 2011 - May 1o 2017

United States

PHD

Publications

Sunetra Das, Rupa Idate, Susan E Lana, Daniel P Regan, Dawn L Duval
Integrated analysis of canine soft tissue sarcomas identifies recurrent mutations in TP53, KMT genes and PDGFB fusions. bioRxiv : the preprint server for biology (2023)
Joanne L Tuohy, Brittney J Byer, Suzanne Royer, Charles Keller, Margaret A Nagai-Singer, Daniel P Regan, Bernard Seguin
Evaluation of Myogenin and MyoD1 as Immunohistochemical Markers of Canine Rhabdomyosarcoma. Veterinary pathology 58 (3) (2021)
Daniel P Regan, Lyndah Chow, Sunetra Das, Laurel Haines, Eric Palmer, Jade N Kurihara, Jonathan W Coy, Alissa Mathias, Douglas H Thamm, Daniel L Gustafson, Steven W Dow
Losartan Blocks Osteosarcoma-Elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit in Canine Metastatic Osteosarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Lauren N Alfino, Kai C Wilczewski-Shirai, Kathryn E Cronise, Jonathan Coy, Kristina Glapa, E J Ehrhart, Joseph B Charles, Dawn L Duval, Daniel P Regan
Role of Periostin Expression in Canine Osteosarcoma Biology and Clinical Outcome. Veterinary pathology 58 (5) (2021)
Tiffany Wormhoudt Martin, Lynn R Griffin, James Custis, Stewart D Ryan, Mary Lafferty, Mary-Keara Boss, Daniel P Regan, Sangeeta Rao, Del Leary, Stephen J Withrow, Susan M LaRue
Outcome and prognosis for canine appendicular osteosarcoma treated with stereotactic body radiation therapy in 123 dogs. Veterinary and comparative oncology 19 (2) (2021)
Kathryn E Cronise, Sunetra Das, Belen G Hernandez, Daniel P Regan, Deanna D Dailey, Robert I McGeachan, Susan E Lana, Rodney L Page, Daniel L Gustafson, Dawn L Duval
Characterizing the molecular and immune landscape of canine bladder cancer. Veterinary and comparative oncology (2021)
Joshua M Abbott, Qiong Zhou, Hector Esquer, Laura Pike, Travis P Broneske, Sébastien Rinaldetti, Adedoyin D Abraham, Dominique A Ramirez, Paul J Lunghofer, Todd M Pitts, Daniel P Regan, Aik Choon Tan, Daniel L Gustafson, Wells A Messersmith, Daniel V LaBarbera
First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer. Molecular cancer therapeutics 19 (8) (2020)
Daniel P Regan, Jonathan W Coy, Kirti Kandhwal Chahal, Lyndah Chow, Jade N Kurihara, Amanda M Guth, Irina Kufareva, Steven W Dow
The Angiotensin Receptor Blocker Losartan Suppresses Growth of Pulmonary Metastases via AT1R-Independent Inhibition of CCR2 Signaling and Monocyte Recruitment. Journal of immunology (Baltimore, Md. : 1950) 202 (10) (2019)

Daniel P Regan.css-eqlu8i{font-size:small;padding-left:4px;} (Daniel Regan)

Publication Activity (10 Years)

Top Topics

Top Venues

Daniel P Regan (Daniel Regan)